Gallup poll finds disinterest in receiving COVID-19 vaccine
Editor's Note A Gallup poll of US adults conducted from July 20 to August 2 finds that 35% of those surveyed would not be interested in receiving a COVID-19 vaccine when one is approved by the Food & Drug Administration. The survey also finds that 41% of non-white Americans would…
FDA authorizes first COVID-19 diagnostic test for screening asymptomatic people
Editor's Note The Food and Drug Administration (FDA) on July 24 reissued its emergency use authorization (EUA) for LabCorp’s COVID-19 RT-PCR Test to include two new indications for use: Testing for individuals who do not have COVID-19 symptoms or who have no reason to suspect COVID-19 infection. Allowing for pooled…
HHS taps Pfizer for large-scale COVID-19 vaccine production
Editor's Note The Department of Health and Human Services (HHS) and Department of Defense on July 22 announced an agreement with Pfizer to produce and deliver 100 million doses of its COVID-19 vaccine in the US, following manufacture and approval. Pfizer will deliver the doses, once the vaccine receives emergency…
Pfizer could have COVID-19 vaccine by October
Editor's Note Food & Drug Administration (FDA) approval of Pfizer’s COVID-19 vaccine could happen in October, the July 12 Time reports. The company was granted FDA Fast Track designation for the vaccine. Pfizer’s vaccine, being developed with its German biotech partner BioNTech, uses a messenger-RNA, genetics-based approach. Pfizer CEO Albert…
Late-stage COVID-19 vaccine trials to start this summer
Editor's Note The National Institute of Allergy and Infectious Diseases director Anthony Fauci says COVID-19 vaccine candidates will start moving into late-stage clinical trials by the end of July, continuing through the summer and into fall, the July 2 Reuters reports. The director of the National Institutes of Health, Dr…
FDA releases COVID-19 update
Editor's Note The Food and Drug Administration (FDA) on June 10 released a COVID-19 update announcing the following actions taken in its response to the pandemic: The FDA and National Institutes of Health have updated the CURE ID crowd-sourcing app to make it easier for healthcare providers to share their…
FDA reissues EUAs revising types of respirators that can be decontaminated
Editor's Note Citing a response to public health concerns, the Food & Drug Administration (FDA) on June 7 reissued certain emergency use authorizations (EUAs) to specify which respirators are appropriate for decontamination and reuse. The FDA determined that certain respirators should not be decontaminated for reuse by healthcare professionals during…
FDA accelerates development of COVID-19 prevention, treatment options
Editor's Note The Food & Drug Administration on May 11 took new actions to accelerate the development of novel prevention and treatment options for COVID-19. The agency is providing guidance documents to make the process for submitting applications to initiate studies for new drugs and biological products more efficient. The…
CMS releases proposed inpatient payment rule for FY 2021
Editor's Note The Centers for Medicare & Medicaid Services (CMS) on May 11 released a proposed rule that increases Medicare inpatient prospective payment system (IPPS) rates by a net of 3.1% in FY 2021, compared to 2020, for acute care hospitals participating in the Hospital Inpatient Quality Reporting Program that…
OR leaders chart new territory for resuming elective surgery
Elective surgical procedures that were temporarily suspended in mid-March are now on the table—or soon will be—at some US facilities. The ban, announced on March 18 by the Centers for Medicare & Medicaid Services (CMS), was enacted to free up resources for facilities overwhelmed by surges of COVID-19 patients. On…
Free Daily News
- Healthgrades names best hospitals for patient outcomes
- FDA announces Class 1 recall for ventilator system
- Research review: Nurse-led preoperative visits reduce anxiety, build trust
- Moody’s downgrades health insurance outlook as medical costs surge
- Criminalizing anesthesia errors has unintended consequences, experts warn
- FDA approves new non-opioid analgesic
- Legislation proposes to halt Medicare physician payment cuts
- Cigna ties executive pay to patient experience
- Proposed tax credit aims to bolster nurse preceptor ranks
- Study links financial conflicts of interest to favorable robotic bariatric surgery research